Merz, M., Salwender, H., Haenel, M., Mai, E. K., Bertsch, U., Kunz, C., Hielscher, T., Blau, I. W., Scheid, C., Hose, D., Seckinger, A., Jauch, A., Hillengass, J., Raab, M. S., Schurich, B., Munder, M., Schmidt-Wolf, I. G., Gerecke, C., Lindemann, H.-W., Zeis, M., Weisel, K., Duerig, J. and Goldschmidt, H. (2015) “Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial”, Haematologica. Pavia, Italy, 100(7), pp. 964-969. doi: 10.3324/haematol.2015.124347.